Accurately predicting surgical and transfusion needs in traumatic brain injury (TBI) patients remains challenging in emergency settings. We developed multiomics data fusion (MDF) models integrating clinical biomarkers, neural radiological imaging, and clinical text mining…
Continue Reading
Introduction to Precision Medicine Innovation
The healthcare landscape is experiencing a transformative shift as technology-driven companies promise to revolutionize how we understand and manage our health. A growing number of organizations offer sophisticated solutions for…
Continue Reading
This systematic review explores the relationship between digital biomarkers, measured using wearable devices, and fatigue in patients with chronic diseases. Studies included in this review focused on individuals with diseases or conditions in 13…
Continue Reading
Depressed mood and anhedonia, the core symptoms of major depressive disorder (MDD), are linked to dysfunction in the brain’s reward and emotion regulation circuits. To develop a predictive model for treatment remission in MDD…
Continue Reading
Dr. Richard S. Isaacson, Neurologist at The Institute for Neurodegenerative Diseases (IND)
Dr. Kellyann Niotis M.D. Neurologist at The Institute for Neurodegenerative Diseases (IND)
Hundreds of millions of people worldwide live with a high risk of…
Continue Reading
Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking.
What You Should Know:
– Advancements in accelerating early Alzheimer’s disease (AD) screening and access to care, proven from three diverse community pilot initiatives, were presented today…
Continue Reading
Sepsis, a life-threatening disease caused by infection, presents a major global health challenge due to its high morbidity and mortality rates. A rapid and precise diagnosis of sepsis is essential for better patient outcomes….
Continue Reading
Routinely collected blood tests can reflect underlying pathophysiological processes. We demonstrate that the dynamics of routinely collected blood tests hold prediction validity in acute Spinal Cord Injury (SCI). Using MIMIC data (n = 2615) for modeling…
Continue Reading
What You Should Know:
– Ultrahuman, the pioneering health optimization company behind the Ultrahuman Ring and M1 (an advanced Continuous Glucose Monitoring platform), today announced the nationwide expansion of Blood Vision, now available across 48…
Continue Reading
Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective…
Continue Reading
